Private equity firm KKR & Co. continued its spurt of acquisitions amid widespread market volatility by making a take-private offer for Swedish life sciences group Biotage AB for 11.6 billion ...

KKR KKR4.43%increase; green up pointing triangle offered to buy the shares in Biotage that it doesn’t already own in a deal that values the Swedish life sciences company at $1.2 billion. The U.S ...

KKR offered to buy the shares in Biotage that it doesn't already own in a deal that values the Swedish life sciences company at $1.2 billion. The U.S. investment firm said it can provide the ...

KKR has offered to buy the shares in Biotage that it doesn’t already own in a deal that values the Swedish life sciences company at $1.2bn. The US investment firm said it can provide the capital and ...

KKR’s offer is for SKr145 per Biotage ordinary share Biotage operates globally serving over 80 countries The acceptance period is expected to commence on or around 13 May KKR has made a $1.2 ...

(RTTNews) - Biotage AB (BITGF.PK), a life sciences company, Tuesday said RWK BidCo AB, a newly formed company indirectly wholly owned by KKR Funds, has proposed to acquire Biotage for about SEK 11 ...

COPENHAGEN (Reuters) -Sweden's Biotage said on Tuesday that KKR had made a cash offer for the Swedish biotechnology firm, valuing it at around 11.6 billion Swedish crowns ($1.22 billion). The ...

MaaT Pharma’s quest to bring a microbiota-based therapy to market has moved a step forward with new data showing a benefit for its MaaT013 candidate in an early-access programme (EAP).

Indigenous people are the stewards of fully 4% of the land area of the United States and represent some 700 distinct communities possessing detailed knowledge of the biota of their homelands. Native ...

The offer by private equity firm KKR comes amid a dry patch for mergers and acquisitions due to US President Donald Trump’s tariffs. Image credit: Shutterstock/ Piotr Swat. Private equity firm KKR has ...